Table 2.
Comparison of the classification performance of the proposed 3DAN method with other methods for AD diagnosis in Strategies 1 and 2 in Table 1
Method | Training: In‐house, Testing: ADNI | Training: ADNI, Testing: In‐house | ||||||
---|---|---|---|---|---|---|---|---|
ACC | SEN | SPE | AUC | ACC | SEN | SPE | AUC | |
3DAN | 0.861 | 0.881 | 0.846 | 0.912 | 0.870 | 0.789 | 0.961 | 0.913 |
ResNet | 0.853 | 0.863 | 0.846 | 0.907 | 0.860 | 0.759 | 0.974 | 0.910 |
VBM | 0.712 | 0.947 | 0.538 | 0.907 | 0.821 | 0.667 | 0.996 | 0.908 |
ROI‐AAL | 0.720 | 0.947 | 0.551 | 0.885 | 0.811 | 0.651 | 0.991 | 0.888 |
ROI‐BNA | 0.744 | 0.960 | 0.584 | 0.901 | 0.813 | 0.651 | 0.996 | 0.894 |
Abbreviations: ACC = accuracy; SEN = sensitivity; SPE = specificity; AUC = area under the curve of the receiver operating characteristic; BNA = Brainnetome Atlas; AAL = anatomical automatic labeling; ROI = region of interest; VBM = voxel‐based morphometric.